CoChat

Aripiprazole augmentation in managing comorbid obsessive–compulsive disorder and bipolar disorder: a case with suicidal attempts

Open access
Lai, Jianbo, Lu, Qiaoqiao, Zhang, Peng, Xu, Tingting, Xu, Yi, Hu, Shaohua · 2016 · Neuropsychiatric Disease and Treatment

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

Comorbid obsessive-compulsive disorder (OCD) and bipolar disorder (BD) have long been an intractable problem in clinical practice. The increased risk of manic/hypomanic switch hinders the use of antidepressants for managing coexisting OCD symptoms in BD patients. We herein present a case of a patient with BD-OCD comorbidity, who was successfully treated with mood stabilizers and aripiprazole augmentation. The young female patient reported recurrent depressive episodes and aggravating compulsive behaviors before hospitalization. Of note, the patient repetitively attempted suicide and reported dangerous driving because of intolerable mental sufferings. The preexisting depressive episode and OCD symptoms prompted the use of paroxetine, which consequently triggered the manic switching. Her diagnosis was revised into bipolar I disorder. Minimal response with mood stabilizers prompted the addition of aripiprazole (a daily dose of 10 mg), which helped to achieve significant remission in emotional and obsessive-compulsive symptoms. This case highlights the appealing efficacy of a small dose of aripiprazole augmentation for treating BD-OCD comorbidity. Well-designed clinical trials are warranted to verify the current findings.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2147/ndt.s122316

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Detailed record of the scores of clinical scales during in-patient treatment. Notes: As quetiapine was already initiated before hospitalization, it was continued at a dose of 400 mg/day after admission and gradually titrated up to 700 mg/d in 2 weeks. Valproate was initiated in the second week and titrated up to 1,000 mg/d in 1 week. Aripiprazole was added 3 weeks after admission at an initial dose of 5 mg/d and increased to 10 mg/d 3 days later. Abbreviations: HAMD-24, Hamilton depression rating scale (24 items); BRMS, Beth–Rafaelsen mania scale; Y-BOCS, Yale–Brown obsessive–compulsive scale.
Figure 1 Detailed record of the scores of clinical scales during in-patient treatment. Notes: As quetiapine was already initiated before hospitalization, it was continued at a dose of 400 mg/day after admission and gradually titrated up to 700 mg/d in 2 weeks. Valproate was initiated in the second week and titrated up to 1,000 mg/d in 1 week. Aripiprazole was added 3 weeks after admission at an initial dose of 5 mg/d and increased to 10 mg/d 3 days later. Abbreviations: HAMD-24, Hamilton depression rating scale (24 items); BRMS, Beth–Rafaelsen mania scale; Y-BOCS, Yale–Brown obsessive–compulsive scale.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 9

Metadata

Authors
Lai, J., Lu, Q., Zhang, P., Xu, T., Xu, Y., & Hu, S.
Affiliations
First Affiliated Hospital Zhejiang University (CN)
Corresponding author
  • Xu, Yi
  • Hu, Shaohua
Venue
Neuropsychiatric Disease and Treatment
Published
2016-12
Volume
Volume 13
Pages
87-90
ISSN
  • 1176-6328 (ISSN-L)
  • 1178-2021
OpenAlex
W2565516624
Cited by
9
References
19
Citations by year
2023: 1 · 2022: 1 · 2019: 2 · 2018: 4 · 2017: 1
FWCI
2.07
Type
journal article
Language
en
Open access
Locations
  • Neuropsychiatric Disease and Treatment (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
  • Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Keywords
aripiprazole, augmentation therapy, obsessive-compulsive disorder, bipolar disorder, comorbidities, bipolar I disorder, suicide attempts, paroxetine, mood stabilizers, depressive episodes, compulsive behavior, bipolar depression

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.